2019 International Conference on Information and Communications Technology (ICOIACT) 2019
DOI: 10.1109/icoiact46704.2019.8938488
|View full text |Cite
|
Sign up to set email alerts
|

Identification of microRNA Targeting Cancer Gene of Colorectal Carcinoma in Caucasian Population

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3
1
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 10 publications
0
2
0
Order By: Relevance
“…Globally, CRC is the second and third leading causes of death in women and men, respectively (20). The aim of cancer therapy is to inhibit proliferation (cytostatic effects) and to induce cell death (cytotoxic effects) of cancer cells (21), to achieve an effective outcome with minimal side effects (23).…”
Section: Discussionmentioning
confidence: 99%
“…Globally, CRC is the second and third leading causes of death in women and men, respectively (20). The aim of cancer therapy is to inhibit proliferation (cytostatic effects) and to induce cell death (cytotoxic effects) of cancer cells (21), to achieve an effective outcome with minimal side effects (23).…”
Section: Discussionmentioning
confidence: 99%
“…The methodology utilized was based on previous papers with detection of gene expressions through the steps of retrieving the data, processing the data, and creating a differential analysis from the expressions (Bernard and Agustriawan, 2019;Ivan, Patricia et al, 2021).…”
Section: Methodsmentioning
confidence: 99%
“…Moreover, the resistance tendency of certain population group against malaria parasite has been observed as well [32]. Cancer is one of the most extensively studied disease in the pharmacogenomics field, in the light of the intensive computational biology tools, as tendencies for prevalence were elucidated in different races [33,34]. Thus, the progress of epigenetics research has leveraged the pharmacogenomics field with various findings of biomarkers for cancer [35].…”
Section: Pharmacogenomics and Personalized Medicinementioning
confidence: 99%